Wall Street Zen Upgrades Tandem Diabetes Care (NASDAQ:TNDM) to “Hold”
Wall Street Zen upgraded shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a sell rating to a hold rating in a research note released on Friday morning. A number of other research analysts have also commented on TNDM. Barclays lowered their price target on Tandem Diabetes Care from $60.00 to $53.00 and set […]
Wall Street Zen upgraded shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a sell rating to a hold rating in a research note released on Friday morning. A number of other research analysts have also commented on TNDM. Barclays lowered their price target on Tandem Diabetes Care from $60.00 to $53.00 and set […]
